Tamsulosin controlled-release - Shiner PharmAlternative Names: Hanlosin
Latest Information Update: 12 Feb 2016
At a glance
- Originator Shiner Pharm Corp
- Class Small molecules; Sulfonamides
- Mechanism of Action Alpha 1a adrenergic-receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Benign prostatic hyperplasia